Proliposomes as an intranasal dosage form for the sustained delivery of propranolol
- 1 June 1995
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 34 (3) , 203-210
- https://doi.org/10.1016/0168-3659(94)00114-a
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Liposome delivery of antisense oligonucleotides: adsorption and efflux characteristics of phosphorothioate oligodeoxynucleotidesJournal of Controlled Release, 1992
- Effect of Viscosity on Particle Size, Deposition, and Clearance of Nasal Delivery Systems Containing DesmopressinJournal of Pharmaceutical Sciences, 1988
- Controlled drug release from a novel liposomal delivery system. I. Investigation of transdermal potentialJournal of Controlled Release, 1987
- Nasal Delivery of Polypeptides I: Nasal Absorption of Enkephalins in RatsJournal of Pharmaceutical Sciences, 1985
- Nasal Drug Delivery System of a Quaternary Ammonium Compound: Clofilium TosylateJournal of Pharmaceutical Sciences, 1984
- Aggregation of dipalmitoylphosphatidylcholine vesiclesBiochemistry, 1982
- Combined High-performance Liquid Chromatographic Procedure for Measuring 4-hydroxypropranolol and Propranolol in Plasma: Pharmacokinetic Measurements Following Conventional and Slow-Release Propranolol AdministrationJournal of Pharmaceutical Sciences, 1981
- Bioavailability of progesterone enhanced by intranasal sprayingCellular and Molecular Life Sciences, 1981
- α-Tocopherol retards autoxidation and prolongs the shelf-life of liposomesInternational Journal of Pharmaceutics, 1981
- Drug Absorption and Metabolism Studies by Use of Portal Vein Infusion in the Rat. I. Pyloric Vein Cannulation and Its Application to Study of First-Pass Effect on Bioavailability of PropranololCHEMICAL & PHARMACEUTICAL BULLETIN, 1972